Petrelintide: The New Weight Loss Peptide That Might Beat The Giant GLP-1s?

Petrelintide just dropped major Phase 2 results — and the weight loss world is paying attention.

In this episode, I break down the latest ZUPREME-1 trial data showing up to 10.7% weight loss with significantly better tolerability than current GLP-1 drugs. Less nausea, almost no vomiting, and high patient retention.

Is Petrelintide the GLP-1 alternative we’ve been waiting for? I cover the results, how it works, the side effects, and what this could mean for the future of weight loss treatments.

 

🔔

Subscribe for more biohacking tips, rate us 5 stars, and join The Human 5.0 Project community for exclusive upgrades. Drop your peptide and longevity stories in the comments!

Follow on IG @Ultimatebiohacker10X

For more longevity insights and protocols, check out biohackerdepot.com – your go-to resource for cutting-edge health optimization strategies.

And if you're sourcing research peptides , peptidesphere.com has a curated selection of peptides and bioregulators with detailed info on quality and applications.

 

#Petrelintide #WeightLossPeptide #OzempicAlternative #Mounjaro #GLP1 #Semaglutide #Tirzepatide #WeightLossDrugs #Peptides #Biohacking #Longevity#Ultimatebiohacker10x;TheHuman5.0Project